chrisvoncsefalvay/vaers-outcomes huggingface dataset:
disorientation; Persistent headache; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of DISORIENTATION (disorientation), HEADACHE (Persistent headache) and VACCINATION SITE PAIN (sore arm) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced DISORIENTATION (disorientation), HEADACHE (Persistent headache) and VACCINATION SITE PAIN (sore arm). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Headache, Disorientation and Vaccination site pain, at an unspecified dose and frequency. At the time of the report, DISORIENTATION (disorientation) and VACCINATION SITE PAIN (sore arm) outcome was unknown and HEADACHE (Persistent headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications details were not reported by the reporter.
I had my vaccination on 09/16/2022. I started to experience aches with cold like symptoms on 01/31/2023. I had a low grade fever and tested COVID-19 Positive on 02/02/2023. I was prescribed Paxlovid on 02/02/2023 and I was ill for 2-5 days to include fatigue.
Blurry vision > Resolved right away lightheady faint Customer said she was anxious, drove in, didn't eat. and had a cup of coffee.  She doesn't do well with blood, needles, etc. Her parent's picked her up but were not worried.
I received my vaccine at approximately 01:00 PM on Friday the 29th of October 2021. Approximately 12 hours later, at 01:00 AM Saturday morning, I began to present with 100 - 101 degree fevers, head and muscle aches, nausea, and severe lower abdominal pain.  Symptoms  persisted through Sunday and into Monday. Abdominal pain persisted and became more severe through the  weekend. At approximately 10:30 AM  Monday, I was seen at an outpatient center and referred to the local hospital for further testing.  After numerous test at the local hospital, at approximately 03:30 PM, I was diagnosed with acute onset appendicitis. At approximately 05:00 PM, I was rushed to surgery to remove my appendix.
Generalized, extremely itchy, burning hives/rash continuous starting 2 weeks after injection. I have never had hives or rash before. No other changes to any foods, medications or otherwise. Treated with Medrol Dosepak, triamcinolone cream and antihistamines without relief.
Itching, swelling and redness 1" area rt upper deltoid with edema and redness, no heat. 2/12 decreased itching, increased soreness, red 2" area with center raised lesion 1 cm with mild heat. Zyrtec RX. Recheck 2/17 or sooner if increased symptoms. 2/17/2003 resolving nicely.  Close case.
This spontaneous report as received from a medical assistant refers to a 19 months old patient of unknown gender. On an unknown date in April 2014, between 12-APR-2014 and 24-APR-2014, the patient was vaccinated with a dose of VARIVAX (Merck) lot # J006358, expiry 23-MAY-2015 ("VFC" stock), 0.5 ml, once, intramuscular. The medical assistant stated there was a power outage on 12-APR-2014 and the VARIVAX (Merck) doses from the freezer needed to be transported to unspecified hospital for proper storage. She stated VARIVAX (Merck) was exposed to 46F for 1 hour, at worst. There were no prior excursions. There was a site visit from local health department on an unspecified date. No adverse effects reported. Additional information has been requested.
patient received a PPV-23 0.5mL and PCV7 0.5ml; 11-16-07 No Side Effects
This spontaneous report was received from a physician- a non-pregnant female patient in her 50's via a company representative. The patient's concurrent conditions and medical history were not reported. On an unknown date (reported as "within the last 6 months"), the patient was vaccinated with ZOSTAVAX 0.65 ml, once (lot #, expiration date, route of administration and anatomical location were not reported). There were no concomitant medications provided. On an unknown date (reported as "within the last 6 months"), the patient experienced swelling around the injection site, after she received ZOSTAVAX. Treatment was not given for adverse event. She did not seek medical attention and there were no lab diagnostics studies performed. The outcome of the event was unknown (reported as "the representative believed that the physician had since recovered"). The relatedness between the event and ZOSTAVAX was not reported. Additional information is not expected as there was no consent for follow up.
Injection site: bright red, size of quarter, arm ached, very tender. Experienced malaise, fatigue, low grade fever, headache. Started on Thursday through the weekend, worse on Monday. Took one week to clear.
Under my armpit, where I got the injection on that side of the arm, under the armpit, it is swollen and it is sore; felt a little rush,  like a slight, just a slight 'rush to my head'; Under my armpit, where I got the injection on that side of the arm, under the armpit, it is swollen and it is sore/swollen lymph node; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 14Aug2021 12:30 (Lot number: FC3181) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Blood pressure measurement" (unspecified if ongoing), notes: Verbatim: Blood pressure; "Blood cholesterol increased" (unspecified if ongoing), notes: Verbatim: High cholesterol. Concomitant medication(s) included: LISINOPRIL; SIMVASTATIN. Vaccination history included: Bnt162b2 (first dose covid-19 vaccine , Lot no. FA7484), administration date: 24Jul2021, for COVID-19 Immunization. The following information was reported: FEELING ABNORMAL (non-serious) with onset Aug2021, outcome "unknown", described as "felt a little rush,  like a slight, just a slight 'rush to my head'"; LYMPHADENOPATHY (non-serious) with onset Aug2021, outcome "unknown", described as "Under my armpit, where I got the injection on that side of the arm, under the armpit, it is swollen and it is sore/swollen lymph node"; LYMPH NODE PAIN (non-serious) with onset 16Aug2021, outcome "unknown", described as "Under my armpit, where I got the injection on that side of the arm, under the armpit, it is swollen and it is sore". Therapeutic measures were not taken as a result of feeling abnormal, lymphadenopathy, lymph node pain.  Additional information: Patient had the second dose of the Pfizer and she felt good except for you know, when she got it, it felt a little rush, like a slight, just a slight 'rush to my head' (not clear). she was feeling good because she heard other people complaining about fever and this and that So, well, she was  feeling great, no problem. But then, this morning when  she woke up, there is like under her armpit, where she got the injection on that side of the arm, under the armpit, it is swollen and it is sore from all day and she could not understand what is going on here, it is my lymph node and what happened is, she was reading, she went to withheld and they gave me like this list of what the side effects are and she didn't see that as one of the side effects. So, she just want to try to find if this is one of the side effect, a swollen lymph node. The experience right now, she was having is swollen lymph node and that is hurting and that is what she want to know if this is one of the side effect or need to go to my doctor tomorrow.  No follow-up attempts are possible. No further information is expected.
gave patient a different Meningococcal vaccine , MD had ordered a vaccine we no longer carry and when asked which one she wanted me to administer (menquadfi or men B) MD said " not Men B" but nurse heard the "Men B".  patient has no symptoms, no reaction.  patients mother notified , aware to report any possible side effects.
Experiencing A-Fib symptoms for last 3 weeks; Jittery; high HR (normally very low); palpitations; shortness of breath with any exertion; This is a spontaneous report from a contactable consumer.  A non-pregnant 37-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration, administered on left arm on 29Mar2021 09:30 (Batch/Lot Number: ER8737) as single dose for COVID-19 immunisation.  Medical history included fibromyalgia, gastrooesophageal reflux disease, IBS, Ehlers Danlos Hypermobility Symdrome, POTS, hypothyroidism and hyperparathyroidism. Patient has no known drug allergies. Concomitant medications included duloxetine hydrochloride (CYMBALTA), buspirone hydrochloride (BUSPAR) and levothyroxine sodium, all taken for an unspecified indication, start and stop date were not reported. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 dose 1 (Lot number: EN6199), ON 08Mar2021 08:45 AM, on left arm for COVID-19 immunisation. The patient has no COVID prior vaccination and not tested post vaccination. 3 weeks (2nd vaccine was on 29Mar) and just put 2 and 2 together. 7+ A-Fib instances recorded on smartwatch. Jittery, high HR (normally very low), palpitations and shortness of breath with any exertion, all on 01Apr2021 06:30. It was unknown if treatment was received. The outcome of the events was not recovered.
Pt had loose stool & vomiting. Hemoccult (-) oral hydration advised.
Please see my prior report for the first dose. I was given Pfizer covid 19 vaccine at 7:45 AM. After few minutes I was itching all over my body.  A few rashes and itching more inside my body. Hitting myself helped the itchiness. I was given 25 mg of Benadryl by mouth and 1 capsule to take home. Perhaps around 9AM I felt tingling and numbing in my face, arms and legs and overall shakiness. I was feeling very confused and not understanding my feelings. I had 2-3 times diarrhea, fast heart beats, swollen lower lip and my throat is feeling tight/swollen, I gave myself epi injection and went to the ER. From the ER, I was given prednisone, Benadryl injection, dextrose and prescriptions for Epipen, Prednisone and Benadryl. It?s been 5 months since my second dose and I still have my confusing symptoms, sometimes worst ? weakness, tingling and numbing in my face, legs, and arms. There are times I can?t sit or stand after few minutes, having lower body discomfort related to bowel movements, uncontrolled urination, brain fog, cognitive issues, bubbling feelings in my arms, legs and thighs, choking even not eating. New symptoms of heart bubbling that makes me cough and pee.  I can?t cope up/remember all my symptoms I don?t really know how to describe them. Had fast heart beats and chest pain that were gone after taking Eliquis. I am now back taking Eliquis due to vein insufficiency. Currently seeing a neurologist and cardiologist.
pt recvd vax inadvertently SQ instead of IM & exp dermatological effects (redness, warmth, swelling to inj site) which subsided p/3-4 days;day p/vax pt saw MD & Augmentin given for poss infect
Incorrect diluent volume resulting in a higher-than-authorized dose. Patient had arm soreness at the site of injection 12 hours after vaccination. Recommended symptomatic care.
Client reports shortness of breath next day after immunization; elevated temperature about 36 hours after immunization.
Hospitalization: 2/13/2023 - 2/16/2023 (3 days); Presentation to the ED: shortness of breath and generalized weakness. COVID + date: 2/13/2023; Treatment: Remdesivir & Decadron; Discharge to: home. 206A21A 7/7/2021.
Injection site and surrounding area became raised, red, hot, and hard. Patient got a fever overnight. Fever broke in the morning, but local reaction has persisted the past 3 days.
pt recvd vax; on 20th day after vax, pt exp fever, elevated BP; flu like sxs; swelling, numbness to extremities; pt was in bed 4 days; saw  MD; still suffers fatigue; Rt shoulder & lt hand weakness, stiffness;
I received FLUZONE High-Dose 2015-16 syr 0.5 ml injection on Oct. 22, 2015 by pharmacist. Pharmacist assured me that I would not have a reaction because she said that the viruses are not live. However, by 6:30pm that day I was very dizzy and feverish. After sleeping that night the next day I was fine.
A report was received from a health care professional on 12/18/03 concerning a 1 year old female vaccinee who inadvertently received Fluvirin on 12/16/03. On 12/16/03 the vaccinee inadvertently received Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Arm pain 8 hours after vaccination continuing for 3 days then returning 7 days after vaccination
The day after having received the Pfizer vaccine, I began to experience tingling, muscle ache and itching in the arm that the injection was administered. The tingling sensation was felt from my upper arm to my fingertips and subsided about 3 weeks after the injection. I continue to experience muscle ache and itching in my upper arm. Both of these side effects are felt throughout the upper arm, beyond the actual injection site. I also have tiny bumps at times on this same upper arm, when scratched they scab and take quite a while to heal. I have not experienced these issues anywhere else on my body, only on the arm in which the injection was administered. I had no experience of these issues prior to this vaccine. Question 21 asks for result or outcome of adverse event(s)... As I had to select an answer, I selected "none of the above". My reasoning is, that at this point in time, I really have no way of knowing if these adverse issues I have experienced from the vaccine will be permanent. I am hopeful that will not be the case; but as of today, almost 5 months after the injection, I continue to experience these adverse reactions.
Information has been received from a registered nurse concerning a 17 year old female with no pertinent medical history or drug reactions/allergies who on 12-MAR-2007 was vaccinated with Gardasil (yeast) (lot # 657006/0188U). Concomitant therapy included FLONASE and PONSTEL. On 13-MAR-2007 the patient experienced a fever of 104F. Unspecified medical attention was sought. The patient missed school and was treated with acetaminophen (TYLENOL). Subsequently, the patient recovered from the fever. Additional information has been requested.
no information on pregnancy hx available had known exposure from spouse who tested positive 1/3/2022 Patient tested negative 1/5/2022 developed sx 1/5/2022- tested negative 1/6/2022 tested positive 1/7/2022 on abbott ID now molecular test
Patient stated that 4 days after first dose he developed vomiting and appetite suppression Patient stated that 2 days after second dose he developed vomiting. around 4 am and it was improving but he still felt puney
I started to feel a little light headed and shaky, so I stayed and they gave me orange juice and they monitored me a little bit about 30 minutes and when I was driving home I felt lightheaded and my heart rate was going up to 180 on my watch. I drove myself to urgent care and they monitored me for a while. I felt like I should have stayed longer at vaccine site.
headaches; dizziness; This is a spontaneous report received from a contactable consumer. A 58-year-old female consumer (patient) reported for a herself that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on 25Jan2021, second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on 22Feb2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. As per the caller, she has experienced headaches and dizziness. Moreover, she asked are these symptoms that have been reported by other people and how long will it last.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Day 4 sharp pain deep in lady thigh radiating  down left leg Day 6 deep sharp pains in middle of back radiating out through chest. Pain is worse and lasts all afternoon  into evening Day 8 pain returns, but this time deep in the right chest and worse. Begins in afternoon and by evening pain is paralyzing, in tears. Attempted to w as l holing on to things to ease the contractions. Yes the pain was as bad a worst contractions from labor. At 3am dressed to go to Ed but decided against  it duevti Covid concerns. Pain most server when I was either sitting  or lying  down. Terrible afraid to take second dose for tear that side effects will be much worse. On the intervening days no pain or paroxysms.
pt was waiting in the waiting area , after 5 minutes patient started itching and had pink skin due to rash
This spontaneous report as received from a pharmacist refers to a 70 year old female patient with allergy to sulfa and no pertinent medical history. On 13-AUG-2013 the patient was vaccinated with a dose of ZOSTAVAX (lot# J002241, Expiration date 21-MAY-2014) (dose and route not reported). Concomitant therapies included cyclobenzaprine hydrochloride, atorvastatin and levothyroxine sodium (manufacturer unknown). On 19-AUG-2013 the patient experienced one inch in diameter red, itchy rash that was hard underneath. The patient sought medical attention  contacted pharmacist. There was no treatment given for adverse event. No lab diagnostics were performed. The outcome of event was reported as not recovered/not resolved. Relationship of the one inch in diameter red, itchy rash that was hard underneath to the ZOSTAVAX was not reported by the pharmacist at the time of report. Additional information has been requested.
Patient tested positive for COVID on 01/06/2021. Patient received out patient monoclonal antibody treatment on 01/10/2021.
Paresthesia in right leg, extreme pain from hips down on both sides. Shooting leg pains thought to be sciatica but later ruled out. Pains behind knee. Debilitating pain episodes in right leg. Inability to walk normally due to numbness in right side 2 lateral toes.
BAD REACTION; ALLERGIC GROWTH UNDER SKIN, ON HEAD AND FACE, AND IT IS NOW GOING DOWN TORSO; COLD SWEATS; RESPIRATORY ISSUES; LOSS OF TASTE; LOSS OF SMELL; SLEEPING 20 HOURS PER DAY; RED AND ITCHY GROWTH; NO ENERGY; This spontaneous report received from a patient concerned a 60 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, expiry: 21-JUN-2021) dose was not reported, administered on 27-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 29-APR-2021, the subject experienced bad reaction. On 29-APR-2021, the subject experienced allergic growth under skin, on head and face, and it is now going down torso. On 29-APR-2021, the subject experienced cold sweats. On 29-APR-2021, the subject experienced respiratory issues. On 29-APR-2021, the subject experienced loss of taste. On 29-APR-2021, the subject experienced loss of smell. On 29-APR-2021, the subject experienced sleeping 20 hours per day. On 29-APR-2021, the subject experienced no energy. On 29-APR-2021, the subject experienced red and itchy growth. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from bad reaction on MAY-2021, and cold sweats, respiratory issues, loss of taste, loss of smell, sleeping 20 hours per day, and no energy on 06-MAY-2021, and had not recovered from allergic growth under skin, on head and face, and it is now going down torso, and red and itchy growth. This report was non-serious.
Pt had a syncopal episode 3 minutes post vaccine . Patient became sweaty, lightheaded, and felt a loss of control of his muscles. He fell with a loss of conscious and hit his head. evaluated by ED for trauma from fall.
After receiving vaccine patient was asked to wait 15 minutes, patient walked around instead of sitting.  A few minutes later she reported to her mother that she felt dizzy.  Mother attempted to hold onto her but she fell to floor, bumping her head. Store manager and pharmacy manager responded and offered to call 911, but mother declined.  Mother stated that patient had severe phobia of needles and this had happened before but she did not indicate this on the VAR. Patient was weak, pale and had her eyes closed but was requesting water and able to answer questions. Through questions found that patient had only eaten a part of an apple that day. We offered her cool water and some gummy bears to brink her blood sugar up. Within a few minutes patient was able to be moved to a chair, opened her eyes and regained color. She remained sitting while eating and drinking. About 15 minutes after original incident patient stated that she felt back to normal and left the store.
it was rpt fr RN concerning a pt who devel zoster p/exposure to child who had been vax
Menveo powder portion reconstitution with sterile water; Menveo powder portion reconstitution with sterile water; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong solution used in drug reconstitution in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   On an unknown date, the patient received Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced wrong solution used in drug reconstitution (Verbatim: Menveo powder portion reconstitution with sterile water) and inappropriate dose of vaccine administered (Verbatim: Menveo powder portion reconstitution with sterile water). The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 21-APR-2023 The reporter was a medical assistant. The reporter reported that the patient received a dose of Menveo vaccine were the powder portion was reconstituted using sterile water. The reporter stated that it was not sure which date this incident was occurred. The vaccine administration facility was the same as primary reporter. The reporter asked to verify if all five patient received Menveo vaccine with a wrong reconstitution, and they can be revaccinated.  The reporter only know that five patient were vaccinated with Menveo vaccine and one of them received Menveo with the wrong reconstitution. The reporter did not consent to follow up. Menveo vaccine reconstituted with sterile water instead of the supplied CYW-135 liquid conjugate, which led to Wrong solution used in drug reconstitution and inappropriate dose of vaccine administered.
Information has been received from the published literature article referring to a 64 year old female patient with asthma and allergy to other unspecified medications. On an unknown date, the patient was vaccinated with a dose of pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown) (dose, route and lot# were unknown). After vaccination, the patient experienced wheeze (bilateral), dizziness and nausea. The initial evaluation was performed in a clinic and the internist doctor provided the diagnosis as vaccine-triggered anaphylaxis with Brighton level was 2. The patient was treated with bronchodilators. Then on an unknown date, the patient recovered. Upon internal review, the event "vaccine-triggered anaphylaxis" was considered to be medically significant. This is one of several reports from the same source (1211USA007452, 0911USA01970, 1207USA012332, 1606USA012239, 1002USA01291, 1606USA012686, 1606USA012688, 1606USA012689, 1606USA012690, 1606USA012691, 1606USA012692, 1606USA012693). Additional information has been requested.